Mino — a pharmaceutical-grade peptide platform serving licensed medical practices, longevity clinics, and aesthetic medicine providers across the United States — is looking to change the narrative of the booming peptide market.
While peptide therapy has largely been exclusive to wealth, access, and regenerative health circles, Mino was founded in hopes of bringing clarity and educations, as peptides are rapidly entering mainstream conversations.
Related: RFK, Jr. Teases Deregulation of Injectable Peptides
Whether the topic is metabolism, recovery, inflammation, cognitive health, skin quality or healthy ageing, Mino's platform provides physician-guided peptide protocols, clinical support infrastructure, pharmaceutical-grade sourcing, and nationwide concierge care designed to bring greater transparency and medical rigor to modern longevity medicine.
This approach counters the current direct-to-consumer wellness brand model and positions Mino as one of the only physician-first platform built around clinical oversight, transparency, and medical rigor in one of healthcare’s fastest-growing categories.
“Mino was built because patients were already asking about peptides long before medicine had created the infrastructure to support safe, informed access,” says Dr. Brandon Howard, Co-Founder and Chief Medical Officer of Mino, board-certified internal medicine hospitalist practicing at Holy Name Medical Center and Hackensack University Medical Center in New Jersey. “But because there’s still so much we’re learning, physicians need to lead that conversation, helping patients access therapies responsibly while advancing the clinical understanding of these compounds.”
Unlike many companies entering the peptide space through telehealth-driven wellness marketing or gray-market sourcing, Mino owns its supply chain end-to-end, including its 503A and 503B compounding facilities and USP <797>-compliant sterile cleanroom. The company uses U.S.-sourced pharmaceutical-grade active ingredients, with every batch independently tested for identity, purity, and potency before release.
Consumers can also access Mino’s physician-guided approach through Mino MD, the company’s nationwide concierge care platform connecting patients with credentialed peptide-literate physicians across all 50 states
